4Front Ventures Corp (FFNTF)
0.089
+0.01
(+7.10%)
USD |
OTCM |
Jun 14, 16:00
4Front Ventures Enterprise Value: 144.77M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 144.77M |
| June 13, 2024 | 139.37M |
| June 12, 2024 | 139.37M |
| June 11, 2024 | 145.69M |
| June 10, 2024 | 145.69M |
| June 07, 2024 | 143.40M |
| June 06, 2024 | 147.52M |
| June 05, 2024 | 148.62M |
| June 04, 2024 | 150.26M |
| June 03, 2024 | 149.53M |
| May 31, 2024 | 154.84M |
| May 30, 2024 | 153.92M |
| May 29, 2024 | 143.49M |
| May 28, 2024 | 145.69M |
| May 24, 2024 | 148.66M |
| May 23, 2024 | 144.77M |
| May 22, 2024 | 154.84M |
| May 21, 2024 | 171.04M |
| May 20, 2024 | 155.30M |
| May 17, 2024 | 183.03M |
| May 16, 2024 | 183.21M |
| May 15, 2024 | 169.39M |
| May 14, 2024 | 165.18M |
| May 13, 2024 | 157.13M |
| May 10, 2024 | 145.23M |
| Date | Value |
|---|---|
| May 09, 2024 | 145.05M |
| May 08, 2024 | 148.16M |
| May 07, 2024 | 138.37M |
| May 06, 2024 | 143.31M |
| May 03, 2024 | 148.43M |
| May 02, 2024 | 144.14M |
| May 01, 2024 | 147.88M |
| April 30, 2024 | 175.13M |
| April 29, 2024 | 145.14M |
| April 26, 2024 | 151.91M |
| April 25, 2024 | 141.94M |
| April 24, 2024 | 145.05M |
| April 23, 2024 | 144.68M |
| April 22, 2024 | 151.81M |
| April 19, 2024 | 145.78M |
| April 18, 2024 | 153.83M |
| April 17, 2024 | 159.31M |
| April 16, 2024 | 159.31M |
| April 15, 2024 | 148.43M |
| April 12, 2024 | 150.17M |
| April 11, 2024 | 159.31M |
| April 10, 2024 | 149.07M |
| April 09, 2024 | 161.60M |
| April 08, 2024 | 159.31M |
| April 05, 2024 | 153.83M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
127.78M
Minimum
Mar 11 2024
1.047B
Maximum
Feb 17 2021
386.51M
Average
329.28M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
| iBio Inc | 30.46M |
| Theriva Biologics Inc | -10.87M |
| Oragenics Inc | 6.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.45M |
| Revenue (Quarterly) | 18.84M |
| Total Expenses (Quarterly) | 23.53M |
| EPS Diluted (Quarterly) | -0.02 |
| Gross Profit Margin (Quarterly) | 40.20% |
| Profit Margin (Quarterly) | -97.94% |
| Earnings Yield | -236.0% |
| Normalized Earnings Yield | -151.28 |